66508-32-5Relevant articles and documents
Deciphering the Late Biosynthetic Steps of Antimalarial Compound FR-900098
Johannes, Tyler W.,DeSieno, Matthew A.,Griffin, Benjamin M.,Thomas, Paul M.,Kelleher, Neil L.,Metcalf, William W.,Zhao, Huimin
experimental part, p. 57 - 64 (2010/08/06)
FR-900098 is a potent chemotherapeutic agent for the treatment of malaria. Here we report the heterologous production of this compound in Escherichia coli by reconstructing the entire biosynthetic pathway using a three-plasmid system. Based on this system, whole-cell feeding assays in combination with in vitro enzymatic activity assays reveal an unusual functional role of nucleotide conjugation and lead to the complete elucidation of the previously unassigned late biosynthetic steps. These studies also suggest a biosynthetic route to a second phosphonate antibiotic, FR-33289. A thorough understanding of the FR-900098 biosynthetic pathway now opens possibilities for metabolic engineering in E. coli to increase production of the antimalarial antibiotic and combinatorial biosynthesis to generate novel derivatives of FR-900098.
Synthesis of the antimalarial drug FR900098 utilizing the nitroso-ene reaction
Fokin, Andrey A.,Yurchenko, Alexander G.,Rodionov, Vladimir N.,Gunchenko, Pavel A.,Yurchenko, Raisa I.,Reichenberg, Armin,Wiesner, Jochen,Hintz, Martin,Jomaa, Hassan,Schreiner, Peter R.
, p. 4379 - 4382 (2008/03/11)
The antimalarial drug FR900098 was prepared from diethyl allylphosphonate involving the nitroso-ene reaction with nitrosocarbonyl methane as the key step followed by hydrogenation and dealkylation. The utilization of dibenzyl allylphosphonate as the start
STUDIES ON PHOSPHONIC ACID ANTIBIOTICS. I. STRUCTURE AND SYNTHESIS OF 3-(N-ACETYL-N-HYDROXYAMINO)PROPYLPHOSPHONIC ACID (FR-900098) AND ITS N-FORMYL ANALOGUE (FR-31564)
Kamiya, Takashi,Hemmi, Keiji,Takeno, Hidekazu,Hashimoto, Masashi
, p. 95 - 98 (2007/10/02)
The structure elucidation of FR-900098 (1) isolated from a microorganism source and the syntheses of FR-900098 and its N-formyl analogue, FR-31564 (2), are described.The latter possesses a superior antimicrobial activity.